NOT-AA-22-013: Notice of NIAAA Withdrawal from Participation in PAR-20-279 "Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)"

Notice of NIAAA Withdrawal from Participation in PAR-20-279 "Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)"

Notice Number:

NOT-AA-22-013

Key Dates

Release Date:

April 22, 2022

Related Announcements

PAR-20-279 - Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)

Issued by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

This notice informs applicants that the National Institute on Alcohol Abuse and Alcoholism (NIAAA) withdraws its participation in PAR-20-279 "Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)", effective immediately.

Inquiries

Please direct all inquiries to:

Brett Hagman, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-0638
Email: [email protected]